Tech Company Financing Transactions
Bios Life Funding Round
On 8/11/2026, Bios Life raised $25 million in Seed investment from Kindred Capital, Redmile Group and Vsquared Ventures.
Transaction Overview
Company Name
Announced On
8/11/2026
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to build its personalized cancer screening and survivorship care platform and support its expansion across the United States.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
Undisclosed
Boston, MA Undisclosed
USA
Boston, MA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
The experience to see what cancer care is missing. A team of oncology innovators, researchers, and AI scientists combining decades at the forefront of innovative cancer care with deep expertise in genomics and machine learning.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ryan Richardson
Chief Medical Officer
Logan Frank
Chief Medical Officer
Christopher Terry
Chief Operating Officer
Zach Taylor
VP - Client Services
Karin Mombourquette
VP - Product Management
Geoff Hyde
Browse more venture capital transactions:
Prev: 8/11/2026: Point2 Technology venture capital transaction
Next: 8/11/2026: Lucrative AI venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to document every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs